Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Stock
-
Number of holders
-
51
-
Total 13F shares, excl. options
-
22.4M
-
Shares change
-
+5.97M
-
Total reported value, excl. options
-
$55.6M
-
Value change
-
+$14.5M
-
Number of buys
-
41
-
Number of sells
-
-14
-
Price
-
$2.48
Significant Holders of CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) as of Q1 2020
62 filings reported holding CDTX - CIDARA THERAPEUTICS INC COM NEW - Stock as of Q1 2020.
CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) has 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.4M shares
.
Largest 10 shareholders include BVF INC/IL (3.83M shares), Bellevue Group AG (2.82M shares), Omega Fund Management, LLC (2.01M shares), 5AM Venture Management, LLC (2.01M shares), INTERWEST VENTURE MANAGEMENT CO (1.36M shares), FRAZIER MANAGEMENT LLC (1.31M shares), Stonepine Capital Management, LLC (1.3M shares), VANGUARD GROUP INC (1.26M shares), RENAISSANCE TECHNOLOGIES LLC (936K shares), and Opaleye Management Inc. (906K shares).
This table shows the top 51 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.